SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-16-083417
Filing Date
2016-02-19
Accepted
2016-02-19 16:16:13
Documents
1
Group Members
FORESITE CAPITAL FUND III, L.P.FORESITE CAPITAL MANAGEMENT II, LLCFORESITE CAPITAL MANAGEMENT III, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SC 13G v432313_sc13g.htm SC 13G 107455
  Complete submission text file 0001144204-16-083417.txt   109201
Mailing Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709
Business Address 7020 KIT CREEK ROAD SUITE 270 RESEARCH TRIANGLE PARK NC 27709 919-313-9650
AERIE PHARMACEUTICALS INC (Subject) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87680 | Film No.: 161442050
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111
Business Address 101 CALIFORNIA STREET, SUITE 4100 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund II, L.P. (Filed by) CIK: 0001594914 (see all company filings)

IRS No.: 901029166 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G